An antiviral pill has, for the first time, been shown to prevent COVID-19 in people exposed to the SARS-CoV-2 virus at home, according to trial results published today in the New England Journal of Medicine1.
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 52 print issues and online access
$199.00 per year
only $3.83 per issue
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-026-01546-0
References
Hayden, F. G. et al. N. Engl. J. Med. 394, 1905–1915 (2026).
Hammond, J. et al. N. Engl. J. Med. 391, 224–234 (2024).
Related Articles
-
👁 Image
COVID drug Paxlovid was hailed as a game-changer. What happened? -
👁 Image
COVID drug drives viral mutations — and now some want to halt its use -
👁 Image
No drug for COVID: ‘the most successful failure in my life’
Subjects
Latest on:
Jobs
-
Associate or Senior Editor (Nature Geoscience – Biogeochemistry)
Job Title: Associate or Senior Editor (Nature Geoscience - Biogeochemistry) Organisation: Nature Portfolio Location: Shanghai, Beijing, Milan and P...
Shanghai, Beijing, Milan and Pune
Springer Nature Ltd
-
Associate or Senior Editor (Nature Geoscience - Solid Earth)
Job Title: Associate or Senior Editor (Nature Geoscience - Solid Earth) Organisation: Nature Portfolio Location: Shanghai, Beijing, Milan and Pune ...
Shanghai, Beijing, Milan and Pune
Springer Nature Ltd
-
Associate or Senior Editor, Nature Reviews Physics
Job Title: Associate or Senior Editor, Nature Reviews Physics Location: Shanghai, Beijing or Madrid – Hybrid working model Applications Deadline: 8...
Shanghai, Beijing or Madrid – Hybrid working model
Springer Nature Ltd
-
Postdoctoral Research Fellow in Semiconductor Devices at NIMS
NIMS invites applications for a Postdoctoral Research Fellow in Semiconductor Devices (approx. 4M-6M JPY per annum, at Tsukuba, Japan).
Tsukuba, Japan (JP)
National Institute for Materials Science (NIMS)
-
Permanent Researcher in Next-Generation Semiconductor Devices at NIMS
NIMS invites applications for a Permanent Researcher in Next-Generation Semiconductor Devices (approx. 6M-10M JPY per annum, at Tsukuba, Japan).
Tsukuba, Japan (JP)
National Institute for Materials Science (NIMS)
